This website is intended for US residents 18 years of age and older

Hodgkin Hub is for people diagnosed with classical Hodgkin lymphoma (also known as Hodgkin's lymphoma or Hodgkin's disease) and their caregivers. Hodgkin Hub provides first-hand stories from Hodgkin lymphoma patients about how they navigated their treatment experiences and became their own advocates.

HODGKIN LYMPHOMA
TREATMENT DISCUSSION GUIDE

questions color icon
Hodgkins Lymphoma - the basics

HODGKIN LYMPHOMA TREATMENT

Hodgkin lymphoma is a cancer that starts in white blood cells called lymphocytes, which are part of the body's immune system.2

Across all types, Hodgkin lymphoma has a 5-year relative survival rate of 89%. Treatment is dependent upon the stage of Hodgkin lymphoma.3

5-year relative survival rate is the percentage of people with a type of cancer who are alive 5 years after treatment compared to the total US population. If the relative 5-year survival rate is 89% for all stages of Hodgkin lymphoma, that means patients diagnosed with Hodgkin lymphoma are 89% as likely as those without that cancer to still be alive 5 years after being diagnosed.3

LEARN MORE

Learn More Arrow

WHAT ARE SOME SYMPTOMS
OF HODGKIN LYMPHOMA?

symptoms

LEARN MORE

Learn More Arrow
play button

Learn About Hodgkin Lymphoma with Dr. Alex Herrera

  1. Key statistics for Hodgkin lymphoma. American Cancer Society. Revised January 19, 2024. Accessed January 24, 2024. https://www.cancer.org/cancer/types/hodgkin-lymphoma/about/key-statistics.html
  2. What is Hodgkin lymphoma? American Cancer Society. Revised May 1, 2018. Accessed January 24, 2024. https://www.cancer.org/cancer/types/hodgkin-lymphoma/about/what-is-hodgkin-disease.html
  3. Survival rates for Hodgkin lymphoma. American Cancer Society. Revised March 2, 2023. Accessed January 24, 2024. https://www.cancer.org/cancer/types/hodgkin-lymphoma/detection-diagnosis-staging/survival-rates.html

HODGKIN HUB PARTNERS

partners

This site is intended only for U.S. residents. The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. Logos are the trademarks of their respective owners. All decisions regarding patient care must be made with a healthcare provider considering the unique characteristics of the patient.

Copyright © 2024 Pfizer Inc.All rights reserved.US-DIS-24-105-MT

Follow us:

youtubefacebookinstagram